Granulocyte colony-stimulating factor therapy for stem cell mobilization following anterior wall myocardial infarction: The CAPITAL STEM MI randomized trial

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 11, 2014, Pages

  Hibbert, Benjamin ^a   Hayley, Bradley ^a   Beanlands, Robert S ^a   Le May, Michel ^a   Davies, Richard ^a   So, Derek ^a   Marquis, Jean François ^a   Labinaz, Marino ^a   Froeschl, Michael ^a   O'Brien, Edward R ^a,b   Burwash, Ian G ^a   Wells, George A ^a   Pourdjabbar, Ali ^a   Simard, Trevor ^a   Atkins, Harold ^c   Glover, Christopher ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION; TREATMENT DURATION; TREATMENT RESPONSE;

ANTERIOR WALL MYOCARDIAL INFARCTION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84905498655     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140133     Document Type: Article

References (27)

1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425.
2. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32. (Pubitemid 44427446)
3. Schächinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
4. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-70.
5. Abdel-Latif A, Bolli R, Zuba-Surma EK, et al. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008;156:216-26.
6. Zohlnhöfer D, Dibra A, Koppara T, et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J Am Coll Cardiol 2008;51:1429-37.
7. Shim W, Mehta A, Lim SY, et al. G-CSF for stem cell therapy in acute myocardial infarction: Friend or foe? Cardiovasc Res 2011;89:20-30.
8. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocytecolony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
9. Ma X, Hibbert B, White D et al. Contribution of recipientderived cells in allograft neointima formation and the response to stent implantation. PLoS One 2008;3:e1894.
10. Zbinden S, Zbinden R, Meier P, et al. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1636-42. (Pubitemid 41531615)
11. Hill JM, Syed MA, Arai AE, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-8. (Pubitemid 41531616)
12. Beohar N, Flaherty JD, Davidson CJ, et al. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing. Catheter Cardiovasc Interv 2007;69:257-66.
13. Le May MR, Davies RF, Dionne R, et al. Comparison of early mortality of paramedic-diagnosed ST-segment elevation myocardial infarction with immediate transport to a designated primary percutaneous coronary intervention center to that of similar patients transported to the nearest hospital. Am J Cardiol 2006;98:1329-33. (Pubitemid 44666640)
14. Hibbert B, Macdougall A, Labinaz M, et al. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry. Circ Cardiovasc Interv 2012;5:805-12.
15. Simard T, Hibbert B, Pourdjabbar A, et al. Percutaneous coronary intervention with or without on-site coronary artery bypass surgery: a systematic review and meta-analysis. Int J Cardiol 2013;187:197-204.
16. Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305-11. (Pubitemid 40460559)
17. Kuhlmann MT, Kirchhof P, Klocke R, et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 2006;203:87-97. (Pubitemid 43139648)
18. Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997;90:903-8. (Pubitemid 27314122)
19. Ellis SG, Penn MS, Bolwell B, et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J 2006;152:1051 e9-14.
20. Zohlnhöfer D, Ott I, Mehilli J, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295:1003-10.
21. Iwanaga K, Takano H, Ohtsuka M, et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 2004;325:1353-9. (Pubitemid 39535912)
22. Ohtsuka M, Takano H, Zou Y, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004;18:851-3.
23. Sesti C, Hale SL, Lutzko C, et al. Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol 2005;46:1662-9. (Pubitemid 41531620)
24. Dawn B, Guo Y, Rezazadeh A, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006;98:1098-105.
25. Ince H, Petzsch M, Kleine HD, et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINEAMI). Circulation 2005;112:3097-106.
26. van der Vleuten PA, Rasoul S, Huurnink W, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord 2008;8:4.
27. Biondi-Zoccai GG, Abate A, Bussani R, et al. Reduced postinfarction myocardial apoptosis in women: A clue to their different clinical course? Heart 2005;91:99-101. (Pubitemid 39665009)